Weimin Tang - Chief Business Officer @ I-Mab Biopharma

Overview

CB Rank (Person)

Weimin Tang is the Chief Business Officer of I-Mab Biopharma and attended Rutgers University.

Number of Current Jobs

Number of Past Jobs

is the

Chief Business Officer

. Additionally,

has had

past job as the

Executive Director, Global Business Development & Licensing

Organization Name	Title At Company	Start Date	End Date
Hengrui Therapeutics	Executive Director, Global Business Development & Licensing	—	—

Hub Name	CB Rank (Hub)
Adage Capital Management Portfolio Companies	79,565
Hony Capital Portfolio Companies	58,139
Hillhouse Investment Portfolio Companies	34,194
VMS Asset Management Portfolio Companies	96,932
Pharmaceutical Public Companies With Fewer Than 50 Employees	59,507
Ally Bridge Group Portfolio Companies	88,331
Cormorant Asset Management Portfolio Companies	70,110
Invus Portfolio Companies	58,644
Avidity Partners Portfolio Companies	77,159
Janus Henderson Investors Portfolio Companies	70,244